JP2016521566A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016521566A5 JP2016521566A5 JP2016518867A JP2016518867A JP2016521566A5 JP 2016521566 A5 JP2016521566 A5 JP 2016521566A5 JP 2016518867 A JP2016518867 A JP 2016518867A JP 2016518867 A JP2016518867 A JP 2016518867A JP 2016521566 A5 JP2016521566 A5 JP 2016521566A5
- Authority
- JP
- Japan
- Prior art keywords
- sev
- rsv
- replication deficient
- vector
- genome replication
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000711408 Murine respirovirus Species 0.000 claims 31
- 230000002950 deficient Effects 0.000 claims 19
- 230000010076 replication Effects 0.000 claims 18
- 108010068327 4-hydroxyphenylpyruvate dioxygenase Proteins 0.000 claims 8
- 239000012634 fragment Substances 0.000 claims 8
- 108020004707 nucleic acids Proteins 0.000 claims 8
- 102000039446 nucleic acids Human genes 0.000 claims 8
- 150000007523 nucleic acids Chemical class 0.000 claims 8
- 230000002163 immunogen Effects 0.000 claims 5
- 150000001413 amino acids Chemical class 0.000 claims 4
- 206010061603 Respiratory syncytial virus infection Diseases 0.000 claims 3
- 230000001086 cytosolic effect Effects 0.000 claims 3
- 229960005486 vaccine Drugs 0.000 claims 3
- 241000124008 Mammalia Species 0.000 claims 2
- 230000000295 complement effect Effects 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 208000017667 Chronic Disease Diseases 0.000 claims 1
- 108020004414 DNA Proteins 0.000 claims 1
- 102000053602 DNA Human genes 0.000 claims 1
- 206010061598 Immunodeficiency Diseases 0.000 claims 1
- 102100034574 P protein Human genes 0.000 claims 1
- 101710181008 P protein Proteins 0.000 claims 1
- 101710177166 Phosphoprotein Proteins 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 238000004113 cell culture Methods 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000007927 intramuscular injection Substances 0.000 claims 1
- 238000010255 intramuscular injection Methods 0.000 claims 1
- 238000007912 intraperitoneal administration Methods 0.000 claims 1
- 239000007928 intraperitoneal injection Substances 0.000 claims 1
- 238000001990 intravenous administration Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 238000007911 parenteral administration Methods 0.000 claims 1
- 108091005981 phosphorylated proteins Proteins 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 230000000241 respiratory effect Effects 0.000 claims 1
- 238000007920 subcutaneous administration Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13002973.9 | 2013-06-10 | ||
| EP13002973 | 2013-06-10 | ||
| PCT/EP2014/001575 WO2014198407A1 (en) | 2013-06-10 | 2014-06-10 | Semi-live respiratory syncytial virus vaccine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016521566A JP2016521566A (ja) | 2016-07-25 |
| JP2016521566A5 true JP2016521566A5 (enExample) | 2017-07-27 |
Family
ID=48578771
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016518867A Pending JP2016521566A (ja) | 2013-06-10 | 2014-06-10 | 半生呼吸器合胞体ウイルスワクチン |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20160120974A1 (enExample) |
| EP (1) | EP3008190A1 (enExample) |
| JP (1) | JP2016521566A (enExample) |
| KR (1) | KR20160025553A (enExample) |
| CN (1) | CN105378090B (enExample) |
| AU (1) | AU2014280545A1 (enExample) |
| BR (1) | BR112015030697A2 (enExample) |
| CA (1) | CA2914821A1 (enExample) |
| EA (1) | EA201592298A1 (enExample) |
| HK (1) | HK1223644A1 (enExample) |
| MX (1) | MX367093B (enExample) |
| WO (1) | WO2014198407A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016144675A1 (en) * | 2015-03-06 | 2016-09-15 | Medimmune, Llc | Vaccine dose and use thereof |
| US20180339038A1 (en) * | 2015-06-12 | 2018-11-29 | Mie University | Human parainfluenza virus type 2 vector and vaccine |
| CN106362144B (zh) * | 2016-10-31 | 2021-02-09 | 武汉三利生物技术有限公司 | 呼吸道合胞病毒疫苗 |
| KR20220164642A (ko) | 2021-06-05 | 2022-12-13 | 이민욱 | 즉석 라면 조리기 |
| JP2025518078A (ja) * | 2022-05-25 | 2025-06-12 | マックス－プランク－ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ | 低減した抗ベクター抗原性を有するワクチン |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102005006388A1 (de) * | 2005-02-11 | 2006-08-24 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Replikationsdefiziente RNA-Viren als Impfstoffe |
| CA2612168A1 (en) * | 2005-06-14 | 2006-12-21 | Dnavec Corporation | Methods for producing antibodies |
-
2014
- 2014-06-10 CA CA2914821A patent/CA2914821A1/en not_active Abandoned
- 2014-06-10 EA EA201592298A patent/EA201592298A1/ru unknown
- 2014-06-10 US US14/896,866 patent/US20160120974A1/en not_active Abandoned
- 2014-06-10 EP EP14729863.2A patent/EP3008190A1/en not_active Withdrawn
- 2014-06-10 MX MX2015016882A patent/MX367093B/es active IP Right Grant
- 2014-06-10 CN CN201480039677.4A patent/CN105378090B/zh not_active Expired - Fee Related
- 2014-06-10 AU AU2014280545A patent/AU2014280545A1/en not_active Abandoned
- 2014-06-10 WO PCT/EP2014/001575 patent/WO2014198407A1/en not_active Ceased
- 2014-06-10 KR KR1020167000452A patent/KR20160025553A/ko not_active Ceased
- 2014-06-10 JP JP2016518867A patent/JP2016521566A/ja active Pending
- 2014-06-10 HK HK16111701.9A patent/HK1223644A1/zh unknown
- 2014-06-10 BR BR112015030697A patent/BR112015030697A2/pt not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016521566A5 (enExample) | ||
| JP2017522907A5 (enExample) | ||
| JP2014526883A5 (enExample) | ||
| JP2014530010A5 (enExample) | ||
| JP2016539946A5 (enExample) | ||
| JP2017511136A (ja) | 腫瘍崩壊ワクシニアウィルス | |
| JP2013537518A5 (enExample) | ||
| IL276210B2 (en) | Mers-cov vaccine | |
| JP2014519817A5 (enExample) | ||
| JP2012515557A5 (enExample) | ||
| JP2017502662A5 (enExample) | ||
| JP2015164424A5 (enExample) | ||
| JP2018524019A5 (enExample) | ||
| JP2013505017A5 (enExample) | ||
| JP2016513471A5 (enExample) | ||
| JP2015524413A5 (enExample) | ||
| Esposito et al. | Respiratory syncytial virus vaccines: an update on those in the immediate pipeline | |
| JP2016521567A5 (enExample) | ||
| HRP20241627T1 (hr) | Pneumolizinski mutanti i postupci za njihovu uporabu | |
| WO2014037440A3 (en) | A novel live attenuated shigella vaccine | |
| JP2013531491A5 (enExample) | ||
| JP2016528176A5 (enExample) | ||
| Zhang et al. | Advances in protein subunit vaccines against H1N1/09 influenza | |
| US20160120974A1 (en) | Semi-live respiratory syncytial virus vaccine | |
| CN105968212B (zh) | 一种鳗鲡创伤弧菌和迟钝爱德华氏菌二联重组蛋白及其制备方法 |